首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi 基因療法

市場調查報告書

商品編碼

1729294

日本基因治療市場報告（按基因類型、載體類型、遞送方式、應用和地區）2025-2033

Japan Gene Therapy Market Report by Gene Type, Vector Type, Delivery Method, Application, and Region 2025-2033

出版日期: 2025年05月01日 | 出版商:

IMARC | 英文 119 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年日本基因治療規模達3.43億美元。展望未來， IMARC Group預計到2033年市場規模將達到11.332億美元，2025-2033年期間的成長率（CAGR）為14.2%。遺傳疾病的盛行率不斷上升、基因編輯技術的最新進展、日本政府實施的支持政策以及對研發 (R&D) 的不斷增加的投資是推動市場發展的一些關鍵因素。

基因治療是醫學領域的突破性方法，旨在透過修改個別細胞內的基因來治療並可能根除疾病。這項先進的技術包括在患者細胞中引入、刪除或改變遺傳物質，主要目的是糾正導致各種疾病的基因異常。基因治療的基本組成部分包括治療性脫氧核糖核酸（DNA）、促進 DNA 轉移到細胞中的傳遞載體以及複雜的基因編輯技術，例如 CRISPR。它可應用於眾多領域，包括癌症治療、病毒感染管理、心血管疾病（CVD）、神經系統疾病、自體免疫疾病、與年齡相關的疾病、特定類型的失明以及遺傳性疾病，包括血友病、囊性纖維化和鐮狀細胞疾病。

日本基因治療市場趨勢：

日本遺傳疾病和癌症的發生率不斷上升，促使人們需要基因治療等創新治療方法，以推動市場成長。此外，CRISPR/Cas9 等基因編輯技術的最新進展提高了基因改造的準確性並提高了治療的成功率，促進了市場的成長。此外，製藥和生物技術公司在研發（R&D）活動方面投入了大量資金，以開發有效和創新的基因療法，從而推動了市場的成長。同時，日本政府實施的支持性法規和政策，加快核准流程並促進基因治療試驗和產品的發展，正在刺激市場成長。除此之外，先進的載體傳遞系統的出現，提高了基因治療的療效，最大限度地減少了潛在的副作用，從而確保了更有效、更安全的治療選擇，支持了市場的成長。此外，醫療保健專業人員和患者對基因療法及其潛在益處的認知不斷提高，這也促進了市場的成長。除此之外，大學、研究機構和公司之間日益成長的策略聯盟和合作，旨在促進創新和拓寬商業化潛力，從而催化市場成長。此外，老年人口不斷增加，極易患上各種與年齡相關的疾病，如帕金森氏症、骨關節炎、阿茲海默症和老年黃斑部病變（AMD），這也推動了市場的成長。預計其他因素也將推動市場成長，包括醫療保健支出的增加、精準醫療的日益普及以及對創新療法的需求的增加。

日本基因治療市場細分：

基因類型洞察：

抗原
細胞因子
腫瘤抑制因子
自殺基因
不足
生長因子
受體
其他

向量類型洞察：

病毒載體
- 腺病毒
- 慢病毒
- 逆轉錄病毒
- 腺相關病毒
- 單純皰疹病毒
- 痘病毒
- 痘苗病毒
- 其他
非病毒技術
- 裸載體和質粒載體
- 基因槍
- 電穿孔
- 脂質體轉染
- 其他

交付方式洞察：

體內基因治療
體外基因治療

應用程式洞察：

腫瘤疾病
罕見疾病
心血管疾病
神經系統疾病
傳染病
其他

本報告回答的關鍵問題：

日本基因治療市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本基因治療市場有何影響？
根據基因類型，日本基因治療市場是如何分類的？
根據載體類型，日本基因治療市場是如何分類的？
根據交付方式，日本基因治療市場是如何分類的？
日本基因治療市場根據應用如何分類？
日本基因治療市場的價值鏈分為哪些階段？
日本基因治療市場的主要促進因素和挑戰是什麼？
日本基因治療市場的結構是怎麼樣的？主要參與者是誰？
日本基因治療市場的競爭程度如何？

本報告回答的關鍵問題：

日本基因治療市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本基因治療市場有何影響？
根據基因類型，日本基因治療市場是如何分類的？
根據載體類型，日本基因治療市場是如何分類的？
根據交付方式，日本基因治療市場是如何分類的？
日本基因治療市場根據應用如何分類？
日本基因治療市場的價值鏈分為哪些階段？
日本基因治療市場的主要促進因素和挑戰是什麼？
日本基因治療市場的結構是怎麼樣的？主要參與者是誰？
日本基因治療市場的競爭程度如何？

The Japan gene therapy size reached USD 343.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,133.2 Million by 2033, exhibiting a growth rate (CAGR) of 14.2% during 2025-2033. The escalating prevalence of genetic disorders, recent advancements in gene editing technologies, implementation of supportive policies by the Government of Japan, and the increasing investment in research and development (R&D) represent some of the key factors driving the market.

Gene therapy is a groundbreaking approach in the medical field, designed to address and potentially eradicate diseases through the modification of genes within an individual's cells. This advanced technique encompasses the introduction, deletion, or alteration of genetic material in a patient's cells, with the primary aim of rectifying the genetic anomalies causing various diseases. The essential components of gene therapy include therapeutic deoxyribonucleic acid (DNA), a delivery vector that facilitates the transfer of DNA into cells, and sophisticated gene-editing technologies, such as CRISPR. It finds application across numerous domains, including cancer treatment, management of viral infections, tackling cardiovascular diseases (CVDs), neurological disorders, autoimmune diseases, age-related illnesses, specific types of blindness, and genetic disorders, including hemophilia, cystic fibrosis, and sickle cell disease.

Japan Gene Therapy Market Trends:

The escalating prevalence of genetic disorders and cancers in Japan, which has prompted the need for innovative treatment methods, such as gene therapy, is propelling the market growth. Additionally, the recent advancements in gene editing technologies such as CRISPR/Cas9, which have improved the accuracy of gene modifications and enhanced the success rates of therapies, are contributing to the market growth. Furthermore, the substantial investments in research and development (R&D) activities by pharmaceutical and biotech companies to develop effective and innovative gene therapies are boosting the market growth. Along with this, the implementation of supportive regulations and policies by the Government of Japan to accelerate approval processes and promote gene therapy trials and products is stimulating the market growth. Besides this, the emergence of advanced vector delivery systems, which improve gene therapy's efficacy and minimize potential side effects, thus ensuring more effective and safer treatment options, is supporting the market growth. Moreover, the heightened awareness about gene therapy and its potential benefits among healthcare professionals and patients is strengthening the market growth. Apart from this, the growing strategic alliances and collaborations among universities, research institutions, and companies to boost innovation and broaden the potential for commercialization are catalyzing the market growth. In addition, the escalating geriatric population, which is highly susceptible to various age-related diseases, such as Parkinson's disease, osteoarthritis, Alzheimer's disease, and age-related macular degeneration (AMD), is fueling the market growth. Other factors, including rising healthcare expenditure, growing adoption of precision medicines, and increasing demand for innovative therapies, are anticipated to drive the market growth.

Japan Gene Therapy Market Segmentation:

Gene Type Insights:

Antigen
Cytokine
Tumor Suppressor
Suicide Gene
Deficiency
Growth Factors
Receptors
Others

Vector Type Insights:

Viral Vector
- Adenoviruses
- Lentiviruses
- Retroviruses
- Adeno-Associated Virus
- Herpes Simplex Virus
- Poxvirus
- Vaccinia Virus
- Others
Non-Viral Techniques
- Naked and Plasmid Vectors
- Gene Gun
- Electroporation
- Lipofection
- Others

Delivery Method Insights:

In-Vivo Gene Therapy
Ex-Vivo Gene Therapy

Application Insights:

Oncological Disorders
Rare diseases
Cardiovascular Diseases
Neurological Disorders
Infectious Disease
Others

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the Japan gene therapy market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan gene therapy market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan gene therapy market?
What is the breakup of the Japan gene therapy market on the basis of gene type?
What is the breakup of the Japan gene therapy market on the basis of vector type?
What is the breakup of the Japan gene therapy market on the basis of delivery method?
What is the breakup of the Japan gene therapy market on the basis of application?
What are the various stages in the value chain of the Japan gene therapy market?
What are the key driving factors and challenges in the Japan gene therapy market?
What is the structure of the Japan gene therapy market and who are the key players?
What is the degree of competition in the Japan gene therapy market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Gene Therapy Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Gene Therapy Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Gene Therapy Market - Breakup by Gene Type

6.1 Antigen
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Cytokine
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Tumor Suppressor
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
6.4 Suicide Gene
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
6.5 Deficiency
- 6.5.1 Overview
- 6.5.2 Historical and Current Market Trends (2019-2024)
- 6.5.3 Market Forecast (2025-2033)
6.6 Growth Factors
- 6.6.1 Overview
- 6.6.2 Historical and Current Market Trends (2019-2024)
- 6.6.3 Market Forecast (2025-2033)
6.7 Receptors
- 6.7.1 Overview
- 6.7.2 Historical and Current Market Trends (2019-2024)
- 6.7.3 Market Forecast (2025-2033)
6.8 Others
- 6.8.1 Overview
- 6.8.2 Historical and Current Market Trends (2019-2024)
- 6.8.3 Market Forecast (2025-2033)

7 Japan Gene Therapy Market - Breakup by Vector Type

7.1 Viral Vector
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Segmentation
  - 7.1.3.1 Adenoviruses
  - 7.1.3.2 Lentiviruses
  - 7.1.3.3 Retroviruses
  - 7.1.3.4 Adeno-Associated Virus
  - 7.1.3.5 Herpes Simplex Virus
  - 7.1.3.6 Poxvirus
  - 7.1.3.7 Vaccinia Virus
  - 7.1.3.8 Others
- 7.1.4 Market Forecast (2025-2033)
7.2 Non-Viral Techniques
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Segmentation
  - 7.2.3.1 Naked and Plasmid Vectors
  - 7.2.3.2 Gene Gun
  - 7.2.3.3 Electroporation
  - 7.2.3.4 Lipofection
  - 7.2.3.5 Others
- 7.2.4 Market Forecast (2025-2033)

8 Japan Gene Therapy Market - Breakup by Delivery Method

8.1 In-Vivo Gene Therapy
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Ex-Vivo Gene Therapy
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)

9 Japan Gene Therapy Market - Breakup by Application

9.1 Oncological Disorders
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Rare Diseases
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Cardiovascular Diseases
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)
9.4 Neurological Disorders
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2019-2024)
- 9.4.3 Market Forecast (2025-2033)
9.5 Infectious Disease
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2019-2024)
- 9.5.3 Market Forecast (2025-2033)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Historical and Current Market Trends (2019-2024)
- 9.6.3 Market Forecast (2025-2033)

10 Japan Gene Therapy Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Services Offered
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Services Offered
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Services Offered
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Services Offered
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Services Offered
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Gene Therapy Market - Industry Analysis

12.1 Drivers, Restraints and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis